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In  the  course  of our  studies  on  the  role  of complement in  antiserum-mediated 
damage to allografts and xenografts of skin, we have observed that, whereas serum 
from C5 deficient mice fails, as expected, to lyse sensitized sheep erythrocytes (SRBC),I 
whole blood from these animals causes measurable lysis even when diluted  1:100 in 
saline. This lytic activity occurs only if the cells have reacted with antibody, and only 
if platelets and early acting components of complement (C) are present. It appears to 
involve mechanisms not previously described in the literature and it may be useful in 
studying the functions of platelets as well as in delineating the cytotoxic potential of 
antibody. We describe here the conditions under which the phenomenon occurs and 
we  present  evidence  for  the  essential  involvement of antibody, complement,  and 
platelets. 
Materials and Methods 
Animals.  Mice were purchased from The Jackson Laboratory, Bar Harbor, ME. A/J, AKR/ 
J, B 10.D2 (old),  DBA/2J, and AKD2F~ mice are C5 deficient, and lack,  therefore, hemolytic 
C; C3H/HeJ, B 10.D2 (new), and CAFI have readily detectable levels of C5 and hemolytic C. 
Rabbits, guinea pigs, and chickens, which served as donors of erythrocytes in one experiment, 
were obtained from local dealers. 
Ant#era.  Mouse anti-SRBC sera were  produced in A/J  (C5-)  and CAFI mice. The mice 
received 20 intraperitoneal injections of a  2% suspension of washed cells at weekly intervals. 
They were bled each week just before injection, beginning 1 wk after the fifth injection. Serum 
obtained from each group of mice was made into a separate pool. Similar procedures were used 
for  the preparation, in A/J  (C5-)  mice, of antisera to erythrocytes of guinea pigs  (GRBC), 
rabbits  (RRBC),  and chickens  (CRBC).  A/J  (C5-)  mice were  used  in  the  preparation of 
antisera to avoid the iinadvertent addition of (25 to experimental systems during the process of 
sensitization of the SRBC. CAFI (BALB/c X A/J) anti-SRBC serum was initially prepared for 
titrating hemolytic C in C5 + mice and was used in the early phases of the study that led to the 
observation that  C5-  whole  blood  can  lyse  sensitized  cells.  Because  BALB/c  mice  have 
hemolytic C, the CAFI serum probably contains small amounts of C5.  However, this serum 
clearly did not reconstitute the hemolytic activity of C5- mice, as shown in the results of the 
two experiments in which it was used (Fig. 1). In all of the other experiments, erythrocytes were 
sensitized with A/J (C5-) antiserum. Rabbit anti-mouse thymus serum (RAMTS) was prepared 
by injecting rabbits first with thymocytes in Freund's adjuvant and 3 wk later with cells alone 
intravenously. 7 d later the animals were bled to form a single large pool of serum. Monoclonal 
anti-SRBC antibodies were prepared by injecting BALB/c mice with  hybridoma cells  and 
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harvesting the resulting ascites. Lines N-S.4.1  (IgM) and N-S.7 (IgG3) were obtained from the 
Salk Institute for Biological Studies; Cell Distribution Center, San Diego, CA. 
SRBC.  Blood was obtained from a single animal at monthly intervals and stored at 4°C in 
Alsevers solution. For radiolabeling, 100 #1 of thrice washed, packed cells were mixed with 200- 
300 #Ci of SlCr (Na 51CrO4, 1 mCi/ml; New England Nuclear, Boston, MA) and incubated in 
a shaking water bath for  1 h. They were washed (three times) with saline and resuspended in 
9.9 ml of veronal buffered saline containing 0.1% gelatin (VBS.G).  For sensitization, 1 ml of 
this  1%  suspension of cells  was  mixed with  an equal  volume of antiserum or  solution of 
monoclonal antibody, and the  mixture was brought to  a  volume of 10 ml, making a  final 
concentration of SRBC 0.1%. The cells and antibody were incubated at room temperature for 
15 min and then stored at 4°C. 
Blood Fractions.  Whole blood was obtained from the retro-orbital sinus of mice in heparinized 
microhematocrit tubes or siliconized pasteur pipettes that had been freshly rinsed with acid 
citrate dextrose (ACD)  (Becton,  Dickinson & Co., Rutherford, N  J). The blood was transferred 
directly to microtiter trays for dilution and assay, or, when blood from several animals was to 
be pooled, to a  13  ×  100-mm siliconized tube containing anticoagulant (heparin or ACD). 
Platelet-rich plasma (prp)  was obtained by centrifuging whole blood at 200 g for  10 min at 
room temperature and carefully aspirating the supernatant material. The fractions so obtained 
contained 4 ×  105-106  platelets/mm  a and were virtually free of leukocytes.  Platelet-poor plasma 
(ppp) was obtained by centrifugation of the blood remaining after removal ofprp at 1,000  g for 
20 rain. These fractions contained 20,000-40,000 platelets/mm  a. 
Test  System.  Doubling dilutions of whole blood, prp, or ppp were made up in 25-/al vol 
using VBS.G  as  a  dilutent in  round-bottomed microtiter  plates  (Dynatech  Laboratories, 
Dynatech Corp., Alexandria, VA). To each dilution was added 25/~1 of 0.1% SRBC; the plates 
were placed on a mieroshaker (Micro-Shaker II, Dynatech Laboratories Inc.) for  15 s, speed 
setting 6,  and then put  at  37°C.  At  15-min intervals the plates were  again placed on the 
microshaker for 15 s. At the end of the incubation period, 150 pl of VBS.G was added to each 
well and the plate was agitated and then centrifuged at  2,000  rpm  (650 g)  for 5  min in a 
refrigerated centrifuge; 100 pl of supernatant fluid was removed and assayed for radioactivity 
in a Gamma Counter (Packard Instrument Co., Inc., Downers Grove, IL). Maximum available 
cpm was determined by counting 25/11 of SRBC and dividing the resulting cpm by 2. 
Lymphoid Cells.  Suspensions of cells were prepared from spleens, lymph nodes, and thymi 
by perfusion with Tris-buffered NH4CI or by gentle teasing with 22-gauge hypodermic needles. 
Large clumps of cells and tissue debris were allowed to settle, and the suspended cells were 
removed, centrifuged at 200 g for 5 min, and then resuspended in L 15 containing  0.25% gelatin. 
When lymphoid cells were used as effector  cells, they were treated exactly as whole blood or 
fractions thereof.  They were  made  up  in doubling dilutions, mixed with  SlCr-SRBC, and 
incubated, with frequent shaking for 2-3 h, at 37°C. When used as targets, they were sensitized 
with RAMTS or alloantiserum, added to doubling dilutions of prp, and incubated at 37 ° with 
frequent shaking. The plates containing the mixtures were then centrifuged, the supernatant 
fluid was removed, and the cells were resuspended in 0.2% trypan blue in saline. A sample from 
each well was examined microscopically to determine the percentage of stained cells. 
Treatment of Mice with Cobra Venom Factor (Cof).  A purified preparation of the anti-comple- 
mentary factor present in cobra venom was obtained from Cordis Laboratories Inc., Miami, 
FL. The lyophilized material was reconstituted to contain 20 U/ml, just before use.  Mice 
received two injections (intraperitoneally) of 0.25 ml (5 U) given 18 h apart. After the second 
injection, blood was drawn and assayed for lytic activity. This schedule of treatment invariably 
reduced hemolytic complement in the serum of C5  + mice to <5% of pretreatment levels. 
Results 
The  phenomenon that  we  report  on  here  is  illustrated in  Fig.  1,  in  which  the 
hemolytic titration curves for plasma and whole blood of C5 +  (C3H/HeJ)  and C5- 
(B 10.D2 old) mice are shown. Attention was first drawn to the phenomenon through 
the observation (Fig. 1 A) that whole blood from C5  + mice was invariably  more active 
in lysing sensitized SRBC  than was  anticipated on  the  basis of the  activity of its 1212  LYSIS  OF  ANTIBODY-COATED CELLS  BY  PLATELETS 
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Reciprocal  dilution  of whole  blood  or  plasma 
FIc.  1.  Lysis of sensitized mCr-SRBC by whole blood (0) and plasma (~) of (A) C5 + (C3H/HeJ) 
mice, and (B) C5-  (B10.D2  old)  mice. Titrations were carried out with blood or plasma from two 
mice of each strain, and the data represent mean values. Spontaneous release =  320 cpm; maximum 
available cpm =  5,580. 
isolated  plasma.  The early plateau  in  the  titration  curve shown here  for plasma  is 
probably due  to  the  anti-C  activity of the  heparin  used  for  anticoagulation.  The 
effect, noted also when citrate was used, was not seen with serum or with plasma that 
contained high levels  of hemolytic C.  Nevertheless,  in  all  of >100 titrations,  whole 
blood was decisively more active than plasma. The ratio of the activity of whole blood 
to that of plasma varied widely among individual mice and was markedly dependent 
on the nature of the antiserum or monoclonal antibody used for sensitization of the 
SRBC, suggesting that a  mechanism other than the classical pathway of C-mediated 
lysis  was involved. This suggestion was strongly supported by the  finding that  C5- 
whole blood had high levels of lytic activity for sensitized SRBC, whereas C5- plasma 
had little or no activity (Fig.  1 B). Low levels of hemolysis observed with some samples 
of C5- plasma are, as shown below, probably because of the presence of small numbers 
of platelets. These titrations were carried out at 37°C, and on the basis of preliminary 
studies, the mixtures were incubated for 3 h with brief (15-s) periods of shaking at  15- 
rain intervals. The time course of the reactions is described in more detail below. 
The  Role  of Antibody  in  the  Lysis  of SRBC  by  C5-  Whole Blood.  Labeled  SRBC 
suspended in saline or in various concentrations of A/J anti-SRBC was mixed with 
C5-  (AKD2F1)  whole  blood  serially  diluted  with  VBS.G,  and  the  mixtures  were 
incubated at  37°C for 2 h. They were then centrifuged at 4°C, and aliquots of the 
supernatant fluids were analyzed for SaCr. The results of these tests are illustrated  in 
Fig. 2. Clearly, the degree of lysis caused by C5- whole blood is directly related to the 
amounts of anti-SRBC serum used for sensitization, and in the absence of such serum, 
there is no detectable lysis. 
Cells Prepared  from  Spleens, Lymph  Nodes, and  Thymi as Effectors of Lysis  of Sensitized 
SRBC.  Because the phenomenon described here resembles other forms of antibody- 
dependent cytotoxicity that are mediated by lymphoreticular cells, we have examined WILLIAM D.  SOPER, SCOTT  P.  BARTLETT, AND HENRY J.  WINN  1213 
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Fio.  2.  (Left)  The role of antibody in the lysis of SICr-SRBC by C5- whole blood. Cells were 
sensitized with varying concentrations of A/J (C5-) anti-SRBC serum and incubated with doubling 
dilutions of B10.D2 whole blood for 2 h at 37°C. Maximum available cpm =  4,750; spontaneous 
release =  130 cpm. Values in parenthesis represent dilutions of whole blood. 
Flo.  3.  (Right) Comparison of the effects of whole blood (O) and lymphoid (spleen) cells ((>) on 
sensitized 5XCr-SRBC. Open symbols, cells diluted in VBS.G; closed symbols, cells diluted in 20% 
fresh C5- plasma. Starting concentration  of spleen cells =  1.7 ×  10V/ml. Maximum cpm =  3,620; 
spontaneous release =  140 cpm. 
the ability of cells prepared  from  spleens, lymph nodes, and  thymi of C5-  mice to 
cause lysis of sensitized SRBC in the experimental circumstances under which whole 
blood has been shown to be effective. Suspensions containing 4  ×  107 to 5 ×  l0  s cells/ 
ml were serially diluted and mixed with labeled SRBC that were suspended in CAF1 
anti-SRBC serum. The mixtures were incubated for 1-3 h  at 37°C with intermittent 
shaking as described above, and the release of 51Cr was determined. In four separate 
experiments, thymus and lymph node cells failed to cause detectable lysis. In two of 
these  experiments,  spleen  cells were  also  inactive,  but  in  the  other  two  cases  they 
caused  small  amounts  of lysis  (Fig.  3).  In  all  four  experiments,  C5-  whole  blood 
caused  readily  detectable  ]ysis  (80-100%  maximum).  Because  the  lymphoid  cell 
suspensions  contained  only  small  amounts  of mouse  plasma,  their  low  activity, or 
inactivity, might  have been  attributed to the lack of essential plasma protein.  This 
point was  examined by assaying whole  blood and  spleen cell suspensions that  had 
been serially diluted with VBS.G fortified with 20% C5- plasma. The added plasma 
caused slightly increased levels of lysis in the mixtures containing spleen cells, but the 
maximum level was only 7%. Whole blood that had been diluted with 20% plasma in 
VBS  had  higher hemolytic activity, particularly at  intermediate dilutions, then  did 
blood diluted in VBS.G.  In both  diluents, however,  100%  lysis was observed at  the 
higher concentrations of blood (Fig. 3). 
It should be noted that the starting concentrations of lymphoid cells used in these 
tests were  from  4  to 45  times as great as the concentrations of leukocytes in mouse 
blood. Thus,  the very low hemolytic activity of these preparations suggests that  the 
lymphoid cells of whole  blood are  not  the  principle effectors of the  lytic reactions 
described here. 
The  Role  of Platelets  in  the  Lysis  of SRBC by  C5-  Whole  Blood.  A  major  role  for 
leukocytes in the phenomenon considered here is further contraindicated on the basis 
of the ratio of the numbers of leukocytes in mouse blood to the numbers of target cells 1214  LYSIS  OF  ANTIBODY-COATED  CELLS  BY  PLATELETS 
used  in  the  test  system.  Mouse  blood  contains  ~10 7  leukocytes/ml,  whereas  the 
concentration of target cells  is  2 ×  107/ml.  It is commonly found that whole blood 
diluted  1:10  causes  100% lysis,  and  in  some cases  100% lysis  is seen  when  blood is 
diluted  1:25.  In those circumstances, the ratio of target cells  to leukocytes is 20:1 or 
50:1. Obviously, the ratios are higher for individual classes  of leukocytes, e.g,,  100- 
250:1  for neutrophils, and  1,200-3,000:1 for monocytes. 
These  considerations  have led  us  to  examine  the  role of platelets  in  the  lysis  of 
SRBC by C5- blood, prp, ppp, and whole blood were serially diluted and mixed with 
sensitized, radiolabeled SRBC. Release of~ZCr was determined after the mixtures had 
been incubated at 37°C for 3 h, and the results are summarized in Fig. 4.  Platelets 
are, clearly, the major effectors of the reaction under consideration, and indeed they 
could account for all of the hemolysis observed with whole blood. The numbers of 
leukocytes contained in prp are so small  (see Materials and Methods) that such cells 
could  not  have  played  a  measurable  role  in  these  tests.  Furthermore,  we  have 
examined,  microscopically, samples  of mixtures  of prp  and  sensitized  SRBC,  and 
invariably have observed adherence of platelets to these erythrocytes before the time 
that lysis occurs. The adherence, which is illustrated  in Fig. 5, appears to be firm as 
judged by its resistance to mechanical shaking, but was not observed when unsensi- 
tized SRBC were used. 
The  Role  of  Nonantibody  Plasma  Constituents  in  the  Lysis  of  Sensitized  SRBC  by 
Platelets.  Anti-SRBC serum and platelets play essential roles in the lytic phenomena 
considered here.  However, fresh plasma was  also present  in  the  test  system, and  it 
remains to be determined whether plasma components also play roles in  lysis.  The 
involvement of C  calls for special consideration, as it  is known that mouse platelets 
bear receptors for C3b and can by means of these receptors attach to sensitized SRBC 
that have reacted with C  (1, 2). 
The  importance  of C3  was  examined  by injecting  C5-  mice  with  purified  Cof 
according to the schedule described above and summarized in  Fig.  6.  Whole blood 
and  prp  from treated  or control mice were  tested  for lytic activity with  sensitized 
SRBC, but data are presented for whole blood only, as they are essentially indistin- 
guishable from those obtained with prp. Treatment with Cof greatly reduced, and in 
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Fla.  4.  Lysis of sensitized ~ICr-SRBC by whole blood (0);  prp  (l);  and ppp  (0) of C5-  (B10.D2 
old) mice. Platelets/mma: whole blood,  106; prp,  1.6 X  108; ppp,  1.5 X  104. Maximum cpm =  1,730; 
spontaneous release =  130 cpm. WILLIAM D.  SOPER, SCOTT  P.  BARTLETT, AND HENRY J.  WINN  1215 
Fl~.  5.  Adherence of platelets to sensitized  SRBC. The SRBC were mixed with A/J anti-SRBC 
(A) or normal A/J serum (B) and then added to C5- prp.  These mixtures were incubated at 37°C 
for 30 min with intermittent shaking,  and then photographed using phase microscopy at  ×  266. 
Numerous platelets were attached to each of the sensitized erythrocytes (A); no association  between 
platelets and unsensitized SRBC was observed (B). 
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Fic.  6.  (Left)  Depression of lytic activity of C5- whole blood by treatment of donors with purified 
Cof. B10.D2  old mice received 5 U of Cofat  18 h and again at 2 h before blood was drawn. Whole 
blood from: normal, control, mice (.); Cof-treated mice (O); Cof-treated mice diluted in 20% fresh 
C5- plasma (4). Maximum cpm =  3,025;  spontaneous release -- 135 cpm. 
Flc.  7.  (Right) The effect  of mechanical shaking at 37°C on lysis of sensitized 51Cr-SRBC  by C5- 
whole blood. All assays were incubated for 180 rain. Shaking at  15-min intervals was discontinued 
after: 30 min (m); 60 rain (O);  120 min (4); or 180 min (O). Maximum cpm =  3,420;  spontaneous 
release =  65,  130, 145, and  190 cpm. 
many  cases completely abrogated,  the lytic activity of whole blood  and  platelet  rich 
plasma.  Lytic activity was, however, restored  by the addition  of fresh  C5-  plasma  to 
the  test  system.  Thus,  it  appears  that  constituents  of fresh  plasma,  probably  early 1216  LYSIS OF ANTIBODY-COATED  CELLS BY PLATELETS 
acting components of C  (C1,2, 4,3),  are essential  for the lysis of SRBC by platelets. 
Failure  of fresh  C5-  plasma  to  restore  full  lytic  activity to  high  concentrations of 
whole blood or prp is probably because of residual effects of Cof. 
The  Effects  of  Temperature  and  Mixing  on  the  Lysis  of SRBC  by  Platelets.  In  the 
experiments described thus far, the test mixtures were incubated at 37°C with mixing 
for brief periods at  15-min intervals.  These conditions were selected on the basis of 
preliminary experiments carried out with whole blood, and their appropriateness  is 
here examined in  more detail.  Whole blood or prp was mixed with sensitized 5aCr- 
SRBC and incubated with frequent mixing at 4°C, room temperature, or 37°C for 
various periods of time up to 3 h. There was no detectable release of 51Cr at 4°C or 
room temperature, whereas up to 100% release was observed at 37°C. 
With respect to the importance of mixing, we have found repeatedly that there is 
no detectable  release  of ~lCr in  mixtures  that  are incubated without shaking.  Fur- 
thermore, as shown in the following experiments, shaking must be practiced through- 
out the period of incubation to achieve optimal levels  of ~XCr release. Multiple assays 
were prepared and incubated at 37°C for 3 h. Mixing was carried out at the start of 
the incubation period and at  15-min intervals thereafter, for periods of time varying, 
for individual assays, from 30 to 180 min. It is apparent from the results of these tests 
(Fig. 7) that under the conditions of incubation, release of 51Cr approaches completion 
only after -3 h. Moreover, there is a direct relationship between the number of times 
that shaking was practiced and the amount of 51Cr released.  However, these data do 
not exclude the possibility that only the shaking at the end of the incubation period 
is essential  for optimal 51Cr release.  This point  was examined  in  an  experiment  in 
which multiple assays were incubated at  37°C for 3 h  with shaking of the mixtures 
carried out according to one of the following schedules:  (a)  every 15 rain throughout 
the course of the reaction; (b) only once, at  165 min, i.e., at  15 min before the end of 
the  incubation  period;  (c)  once,  at  15  min  after  the  beginning  of the  incubation 
period; (d)  not at all. The results of these tests,  shown in Fig. 8, indicate that shaking 
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FIG.  8.  The  effect  of  mechanical  shaking  at  37°C  on  lysis  of  sensitized  ~ICr-SRBC  by  C5- 
(AKD2F1)  whole blood.  All assays were incubated  for  180 rain. Shaking was carried out as follows: 
at  t5-min  intervals  throughout  the  period  of  incubation  (#);  once,  15  min  after  the  start  of 
incubation  (~);  once,  15 min before the end of the incubation period (.);  not at all (O). Maximum 
cpm =  2,560;  spontaneous  release =  96,  75,  74, and 32 cpm. WILLIAM D.  SOPER,  SCOTT  P.  BARTLETT, AND HENRY J.  WINN  1217 
Platelet-mediated Lysis of Cells other than SRBC 
ERv'rnROCYXES FROM OTHER SPECIES.  RRBC, GRBC, and CRBC were labeled with 
51Cr and sensitized with mouse antisera of appropriate specificity as described above 
for SRBC.  Sensitized erythrocytes were mixed with doubling dilution of C5- whole 
blood or prp, and incubated at 37°C  for 3  h  with intermittent shaking, after which 
the release of 51Cr was determined. There was no significant release of 51Cr from cells 
incubated  in  platelet-free, C5-  plasma,  but  as shown  in Table  I, all three types of 
sensitized erythrocytes were  lysed in  dose-dependent  form  by whole  blood or prp. 
Sensitized ceils that  had been  incubated in prp were also examined  for evidence of 
immune  adherence.  Without  exception,  lysis was  preceded  by firm  attachment  of 
platelets  to  cell  surfaces.  Such  attachment  was  never  observed  in  the  absence  of 
antibody or subsequent lysis. 
NUCLEATED CELLS FROM  MICE, RATS,  AND GUINEA PIGS.  Suspensions of cells prepared 
from  spleens, lymph  nodes, or thymi  were  sensitized with  either alloantisera  (anti- 
major  histocompatibility complex or  anti-Thy-l.2)  or  xenoantisera  (RAMTS)  and 
then  incubated  at  37°C  with  C5-  prp.  At  intervals  up  to  4  h,  samples  of  the 
suspensions were  removed  and  examined  for cell viability after addition of trypan 
blue. There was no detectable killing of the target cells by platelets, though all three 
types of sensitized cells were killed using fresh rabbit serum as a  source of C  and there 
was no evident association of platelets and target cells. Similar tests were carried out 
with  tumor cells obtained  from  mice, rats, and  guinea pigs, and  again we failed to 
observe platelet-mediated killing or  evidence of immune  adherence,  It  is  not  clear 
whether failure to observe lysis of the nucleated cells used here is attributable to their 
resistance to the platelet-associated lysin or to their inability to bind platelets under 
the conditions in which the tests were carried out. However, we report elsewhere (S. 
P,  Bartlett,  K.  S.  Stenger,  and  H. J.  Winn,  manuscript  in  preparation)  a  platelet- 
derived lysin that acts on nonsensitized nucleated cells as well as on erythrocytes. 
Platelet-mediated Lysis of SRBC Sensitized With IgG1 and IgM Monoclonal Antibodies.  We 
shall report separately on  a  systematic study of the biological properties of various 
classes of mouse  immunoglobulins  (S.  P.  Bartlett,  K.  S.  Stenger,  and  H. J.  Winn, 
manuscript  in preparation).  However, it is pertinent to consider here the abilities of 
some  so-called non-lytic  immunoglobulins  to  prepare  SRBC  for  platelet-mediated 
TABLE  I 
Lysis of Sensitized E~ythrocytes of Various Species by C5- Whole Blood* 
Dilution of whole  RRBC +  GRBC +  CRBC +  SRBC +  SRBC + 
blood  aRRBC  aGRBC  aCRBC  MclgM~  MclgG1 
¢pm 
1:4  4170  2460  962  1930  2620 
1:8  2730  1380  313  930  1725 
1:16  1570  590  155  625  530 
1 : 32  680  490  90  480  70 
1:64  340  200  24  110  45 
1:128  0  0  48  65  105 
Spontaneous cpm  300  260  <5  117  205 
Maximum cpm  4800  4460  2140  3150  3740 
* Individual tests were carried out on different dates with different preparations of whole blood. 
:1: Mc, Monoclonal anti-SRBC. 1218  LYSIS  OF  ANTIBODY-COATED  CELLS  BY  PLATELETS 
lysis. Cells sensitized with either monoclonal IgGa or IgM antibodies were incubated 
at 37°C for 3 h with C5  + plasma, C5- plasma, or C5- whole blood and examined for 
release of 5aCr as described above. In confirmation of an earlier study by Klaus et al. 
(3), we found no significant release during incubation with either C5  + or C5- plasma, 
but as shown in Table I, there was readily detectable lysis of cells incubated with C5- 
whole blood. Similar results were obtained in related studies with IgG2a, IgG2b, and 
IgG3 monoclonal anti-SRBC reagents,  The initiation  of platelet-mediated  damage 
by antibodies that do not cause lysis through activation of the late-acting components 
of C  is not inconsistent with the observation that early acting components of C  may 
be required for platelet activity (3). 
The  Fate  of  Nonsensitized  Bystander  Cells  During  the  Lysis  of  Sensitized  Cells  by 
Platelets.  Mouse platelets  are  known to adhere  to cells  or antigen-coated particles 
that have reacted with antibody and early acting components of C, a  phenomenon 
that has been designated immune adherence (4). As stated above, we have observed 
such adherence in our test system and it seems likely that it is an essential forerunner 
of lysis. The question arises as to whether platelets  lyse only the cells  to which they 
have become attached, oi whether they release a  lytic agent that may act on other, 
nonsensitized cells.  In an effort to resolve this issue,  whole blood or prp was mixed 
with  sensitized  but  unlabeled  GRBC  and  unsensitized  SlCr-labeled  SRBC  and 
incubated for 3 h with intermittent shaking. Release of 51Cr from the bystander cells 
was  then  determined.  There was no significant  release  from unsensitized  cells  that 
had been  intimately mixed with  sensitized unlabeled  cells  and platelets  (Table II), 
although  in  control  mixtures,  both GRBC  and  SRBC  labeled  and  sensitized  with 
antibody released  readily detectable amounts of 51Cr. Lysis is evidently confined to 
those cells  that  are coated with antibody and C, and have, thereby, interacted with 
platelets. 
Discussion 
Platelets  have long been known to interact with immune aggregates in vitro, and 
their tendency to adhere to sensitized cells, first described by Nelson (4), is now widely 
recognized and occasionally used  for the detection of antibodies  reactive with ceil- 
TABLE II 
Unsensitized, Bystander Cells Are Not Lysed When Incubated with Sensitized Cells and 
Whole Blood or prp 
51Cr-labeled cells:  SRBC  GRBC  SRBC  SRBC 
Unlabeled cells:  GRBC  SRBC  GRBC  SRBC 
Antiserum:  aGRBC  aGRBC  aSRBC  aSRBC 
Dilution of effectors  WB*  prp  WB  prp  WB  prp  WB  prp 
1:2  25  60  400  790  730  675  450  524 
1:4  40  50  510  290  505  250  540  305 
1:8  35  40  410  220  275  82  310  83 
1:16  30  30  140  40  70  35  155  40 
1:32  20  50  50  0  30  10  65  15 
Spontaneous cpm  22  96  64  64 
Maximum cpm  2,700  2,650  2,370  2,370 
* Results are expressed as net cpm, i.e.,  observed cpm -  spontaneous release cpm. WILLIAM D.  SOPER, SCOTT  P.  BARTLETT, AND HENRY J. WINN  1219 
surface antigens.  These reactions, which depend on membrane receptors for C3b or 
for the Fc portion of antibody molecules, have been shown to lead to the release of 
platelet granules and, in turn, to the liberation of substances with diverse biological 
properties--vasoactive, chemotactic, thrombogenic, or microbicidal (5-7). There are, 
however, no reports of the direct cytotoxicity of platelets for cells to which they have 
become attached.  It may seem surprising that such activity has not been previously 
observed, but it has probably been masked by the lytic properties of plasma comple- 
ment or obscured by the unusual test conditions required for its optimal expression. 
Our observations have depended on the use of C5- mice, whose blood contains early 
acting components of C  but  not  a  complete lytic system, and  on the  use of whole 
blood rather than serum, a  feature that  inadvertently introduced  platelets into the 
test system. It is our view that platelets adhere to cells that have bound antibody and 
early  acting  components  of C,  and  are  induced  thereby  to  release,  among  other 
biologically active substances, a  cytolysin. Our data do not provide direct evidence 
for the release ofa cytotoxic substance by platelets, but we favor this view on the basis 
of observations that the clotting of whole blood and prp leads to the appearance of 
cytolytic activity in the resulting serum, whereas no such activity appears in serum 
derived  from platelet-free plasma  (S.  P.  Bartlett,  K.  S.  Stenger,  and  H. J.  Winn, 
manuscript in preparation). Similar findings have been reported for a platelet-derived 
bactericidal agent (8), and it is likely that this substance is also released by platelets 
that  adhere  to antibody-coated ceils including  bacterial  cells.  Indeed,  the cytolytic 
agent that we have described here may be identical with the bactericidin, and a major 
function of the antigen-antibody-induced release reaction may be to provide protec- 
tion against microbial infection or other parasitic infestation. 
We have been unable to show that sensitized nucleated cells, other than CRBC, are 
lysed by platelets.  However, this may be traced to the failure of these cells to bind 
platelets  in  the  circumstances  in  which  our experiments  have been  conducted.  As 
mentioned  above,  we  have  evidence  that  platelets  can  be  induced  to  release  a 
substance that lyses nucleated cells as well as erythrocytes. Furthermore, it has been 
reported  (9) that the addition of platelets to mixtures of tumor cells and anti-tumor 
cell sera enhances the neutralizing effects of the serum that occurs when the mixtures 
are injected into hosts that are susceptible to the tumor. 
Thus, the lytic reaction that we describe may play roles in the destruction of viral 
infected  cells,  tumor  cells,  or  grafts  of  foreign  cells,  and  its  significance  will  be 
understood only after a great deal more study. It is already evident, however, that it 
is a remarkably effective reaction in the sense that virtually complete lysis is observed 
even when approximately equal numbers of platelets and target cells are present; in 
view of the relatively large numbers of platelets  in circulating blood, it looms as a 
major effector mechanism  of the  immune  response.  From  this  point  of view,  it  is 
particularly important to note that most, and perhaps all, classes of mouse immuno- 
globulins can initiate the platelet-mediated lytic reaction. 
With  respect  to  the  detailed  mechanism  of the  lytic  reaction  and  the  optimal 
conditions under which it occurs in vitro, there are several aspects of the phenomenon 
that call for further study. That nonsensitized  bystander cells are unaffected by the 
reaction of sensitized cells with platelets suggests the need for close contact between 
effector and  target  cells,  but  that  does  not  exclude  the  involvement  of a  soluble 
mediator released  by platelets.  Indeed,  as  mentioned  above, we  have discovered a 1220  LYSIS OF ANTIBODY-COATED CELLS BY PLATELETS 
potential mediator and the isolation and characterization of this substance should be 
helpful in elucidating the mechanism of lysis. 
Among the experimental conditions  found essential to the expression of the lytic 
reaction,  the requirement  for frequent  shaking is puzzling,  especially in so far as it 
contrasts sharply with observations made on other forms of cell-rnediated cytotoxicity. 
It is difficult to evaluate the significance of this finding because of the complexity of 
the overall lytic phenomenon,  which  involves the  interactions  of antibody,  C,  and 
platelets with target cells. The optimal concentrations of these constituents  and the 
conditions under which they contribute maximally to the lyric reaction remain to be 
determined.  Nevertheless,  our  data  establish  the  general  circumstances  in  which 
platelet-mediated  lysis of sensitized cells can be observed routinely and  in  a  highly 
reproducible manner, and they provide the means for probing further this intriguing 
and potentially important phenomenon. 
Summary 
Antibody-coated  erythrocytes are  lysed  by murine  C5-  whole  blood  but  not  by 
plasma separated from such blood. The lytic activity has been shown to derive from 
platelets that attach to sensitized cells probably through membrane receptors for C3b. 
Whole blood or platelet-rich plasma (prp) obtained from mice that have been treated 
with purified  cobra venom factor has little or no activity unless  it  is fortified with 
fresh C5- plasma. Lysis is observed only if the reactants are incubated at 37°C  and 
mechanical  shaking  is  practiced,  at  least  intermittently,  throughout  the  period  of 
incubation. Adherence of platelets and subsequent lysis are mediated by antibodies of 
a variety ofimmunoglobulin classes, including those that fail to mediate complement- 
dependent lysis. Platelet-mediated lysis is limited to cells to which the platelets adhere; 
5aCr labeled, unsensitized cells that are mixed with prp and sensitized, unlabeled cells 
do not  release 51Cr. Normal murine lymphoid cells and ascites tumor cells of mice, 
rats, and guinea pigs were apparently unaffected by sensitization and incubation with 
prp. However, because adherence of platelets to these sensitized cells was not observed, 
it is not clear whether the cells are resistant to the lyric action of platelets or whether 
the conditions of incubation were unfavorable for the attachment of platelets to the 
surfaces of nucleated cells. The significance of the lytic reaction described here is not 
known  but  may lie  in  antibody  mediated  release  of microbicidal  substances  from 
platelets. 
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